Previous 10 | Next 10 |
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
Grifols S.A. (GRFS) is expected to report $0.22 for Q4 2023
2024-02-21 12:51:10 ET More on Grifols S.A. Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum Grifols appoints new CEO; founding family members to leave executive roles Grifols...
2024-02-09 22:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-09 16:51:46 ET Gainers: Amtech Systems ( ASYS ) +7% . Oportun Financial ( OPRT ) +5% . Nutanix ( NTNX ) +3% . Gritstone bio ( GRTS ) +2% . Grifols ( GRFS ) +2% . Losers: Applied Blockchain ( APLD ) -10% . ...
2024-02-05 14:20:46 ET More on Grifols Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum Grifols’ banking exposure under ECB scrutiny: Reuters ELAB, KIND and RLX among p...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...
SAN FRANCISCO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Grifols, S.A. (NASDAQ: GRFS) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/grfs Contact An Attorney Now: GRFS@hbsslaw.com 844-916-08...
2024-01-17 14:56:12 ET More on Grifols S.A. Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum ELAB, KIND and RLX among pre-market losers Haier Group still looking to buy Shangh...
2024-01-17 09:00:32 ET Losers: DatChat DATS -32% plans to sell shares through public offering . Acurx Pharmaceuticals ( NASDAQ: ACXP ) -24% announces positive comparative Microbiology and Microbiome data for Ibezapolstat from phase 2b clinical trial in CDI ...
News, Short Squeeze, Breakout and More Instantly...
Grifols S.A. Company Name:
GRFS Stock Symbol:
NASDAQ Market:
Grifols 2023 Annual Report on Form 20-F filed with the SEC PR Newswire BARCELONA, Spain , April 19, 2024 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived me...
U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday. Shares of CarMax, Inc. (NYSE: KMX) fell sha...
2024-03-23 01:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...